Practically pre-commercialprocurement can take the form of a single public procurement contract managed in three phases; the first phase being a solution exploration phase, followed by a prototyping phase and finally a test series.

In the first phase a number of offers from competing suppliers could be selected. Thenumber of suppliers developing in parallel is progressively reduced after each phase subsequent to evaluations. In the final phase at least two contractors should remain to ensure a future competitive market.


The proposals can be presented individually or as part of a consortium.

The consortium could consist on any kind of organization: SMS, Multinationals, Universities, Technological Centre, etc. There is not geographic restriction, the partnership could be national or international.

The 60% of the R&D tasks must be carryed out in EU countries or FP7 associated members.

Legal documentation related with the consortium won't be required, only administrative information from each consortium partners.

The consortium structure has to be defined since the begining (phase 0)

The ownership of all the knowledge generated by bidders belongs always to them whether or not ending the PCP process.

Yes. The Usability Evaluation will take place along the PCP process. Testers will be recruited within the populations of patients who are exposed to heart failure risk factors and doctors.

Any country as long as the R&D will take place mostly  (60% from the R&D) in EU countries or FP7 associated countries.


  • The IP rights stays within the company. The three procuring authorities have non-exclusive licences and sub-licences of use:
    • Only of use, not of exploitation.
    • Right of use of our own propose the knowledge generated during the PCP procedure.
    • Use this knowledge to provide health care services which are founded by public administration.
    • Only within these three regions: Catalonia, South of Denmark, and Scotland.
    • Non-exclusive means that each bidder has also the right to sell their solution in the three procuring regions. Bidders provide a specific solution to the market, and this could be requested by the health care public administration instead of perform it by themselves based on the licence of use purchased.
  • Call back provision:
    • In the final phase only two providers are founded to develop a final solution. After the end of PCP procedure, in almost 3 years they have to be able to commercialize a solution based on that specific knowledge. If they haven´t done so already the Procurer Authorities have the possibility of calling back the IP produced in the PCP process. The IP back call back to the Procurers to find someone who can generate a commercial product.

The IP constrictions affects only to the solutions generated at the PCP process, if existing product or knowhow is provided to determine that solution, the IP rights of them are reserved to the bidder. So before starting Phase 1 should be defined the background every bidder provides. The bidder shall notify in writing with full and complete information of any self or third party owned pre-existing or Background IPRs that may in any way affect any use rights corresponding to the Procuring Authorities. These notifications will be provided by the Bidders with the necessary authorizations at no cost for the Procuring Authorities that, if necessary, will be reinstated as legitimate users according to the terms exposed in the Invitation to Tender, including as the case may be, the substitution of equivalent solutions or products that do not infringe third party IPRs.

Budget distribution
  Total budget Budget per bidder
Phase 1  420,000€ 70,000€
Phase 2 525,000€  175,000€
Phase 3  1,155,000€ 577,500€
Total PCP 2,100,000€ NA


Phase one (solution design): 3 months of execution

Phase two (prototype): 6 months of execution

Phase three (testing phase): 9 months of execution

Yes, will be done. The first phases will have everything in English, but once we start testing with clinicians and patients (phase 3), we need local languages. The technical testing in the early phases can be in English